Literature DB >> 29654427

Sociodemographic disparities in the occurrence of medical conditions among adolescent and young adult Hodgkin lymphoma survivors.

Theresa H M Keegan1, Qian Li2, Amy Steele2, Elysia M Alvarez3, Ann Brunson2, Christopher R Flowers4, Sally L Glaser5,6, Ted Wun2.   

Abstract

PURPOSE: Hodgkin lymphoma (HL) survivors experience high risks of second cancers and cardiovascular disease, but no studies have considered whether the occurrence of these and other medical conditions differ by sociodemographic factors in adolescent and young adult (AYA) survivors.
METHODS: Data for 5,085 patients aged 15-39 when diagnosed with HL during 1996-2012 and surviving ≥ 2 years were obtained from the California Cancer Registry and linked to hospitalization data. We examined the impact of race/ethnicity, neighborhood socioeconomic status (SES), and health insurance on the occurrence of medical conditions (≥ 2 years after diagnosis) and the impact of medical conditions on survival using multivariable Cox proportional hazards regression.
RESULTS: Twenty-six percent of AYAs experienced at least one medical condition and 15% had ≥ 2 medical conditions after treatment for HL. In multivariable analyses, Black HL survivors had a higher likelihood (vs. non-Hispanic Whites) of endocrine [hazard ratio (HR) = 1.37, 95% confidence interval (CI) 1.05-1.78] and circulatory system diseases (HR = 1.58, CI 1.17-2.14); Hispanics had a higher likelihood of endocrine diseases [HR = 1.24 (1.04-1.48)]. AYAs with public or no insurance (vs. private/military) had higher likelihood of circulatory system diseases, respiratory system diseases, chronic kidney disease/renal failure, liver disease, and endocrine diseases. AYAs residing in low SES neighborhoods (vs. high) had higher likelihood of respiratory system and endocrine diseases. AYAs with these medical conditions or second cancers had an over twofold increased risk of death.
CONCLUSION: Strategies to improve health care utilization for surveillance and secondary prevention among AYA HL survivors at increased risk of medical conditions may improve outcomes.

Entities:  

Keywords:  Adolescent; Circulatory system; Endocrine system; Hodgkin lymphoma; Insurance; Race/ethnicity; Respiratory system; Second cancer; Young adult

Mesh:

Year:  2018        PMID: 29654427      PMCID: PMC6422023          DOI: 10.1007/s10552-018-1025-0

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.532


  37 in total

Review 1.  Late effects in the era of modern therapy for Hodgkin lymphoma.

Authors:  David C Hodgson
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2011

2.  Health status of adolescent and young adult cancer survivors.

Authors:  Eric Tai; Natasha Buchanan; Julie Townsend; Temeika Fairley; Angela Moore; Lisa C Richardson
Journal:  Cancer       Date:  2012-06-11       Impact factor: 6.860

3.  Long-term Health Outcomes in Survivors of Childhood Cancer Diagnosed Between 1990 and 2000 in a Large US Integrated Health Care System.

Authors:  Chun Chao; Lanfang Xu; Elizabeth Bell; Roberto Cooper; Lisa Mueller
Journal:  J Pediatr Hematol Oncol       Date:  2016-03       Impact factor: 1.289

Review 4.  Current survivorship recommendations for patients with Hodgkin lymphoma: focus on late effects.

Authors:  Andrea K Ng
Journal:  Blood       Date:  2014-11-27       Impact factor: 22.113

Review 5.  Identifying and addressing the needs of adolescents and young adults with cancer: summary of an Institute of Medicine workshop.

Authors:  Sharyl J Nass; Lynda K Beaupin; Wendy Demark-Wahnefried; Karen Fasciano; Patricia A Ganz; Brandon Hayes-Lattin; Melissa M Hudson; Brenda Nevidjon; Kevin C Oeffinger; Ruth Rechis; Lisa C Richardson; Nita L Seibel; Ashley W Smith
Journal:  Oncologist       Date:  2015-01-07

6.  Influence of new late effects on quality of life over time in Hodgkin lymphoma Survivors: a longitudinal survey study.

Authors:  N Khimani; Y-H Chen; P M Mauch; C Recklitis; L Diller; B Silver; A K Ng
Journal:  Ann Oncol       Date:  2012-08-08       Impact factor: 32.976

7.  Underascertainment of radiotherapy receipt in Surveillance, Epidemiology, and End Results registry data.

Authors:  Reshma Jagsi; Paul Abrahamse; Sarah T Hawley; John J Graff; Ann S Hamilton; Steven J Katz
Journal:  Cancer       Date:  2011-06-29       Impact factor: 6.860

8.  Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk.

Authors:  Frederika A van Nimwegen; Michael Schaapveld; Cécile P M Janus; Augustinus D G Krol; Eefke J Petersen; John M M Raemaekers; Wouter E M Kok; Berthe M P Aleman; Flora E van Leeuwen
Journal:  JAMA Intern Med       Date:  2015-06       Impact factor: 21.873

9.  Disparities in survival after Hodgkin lymphoma: a population-based study.

Authors:  Theresa H M Keegan; Christina A Clarke; Ellen T Chang; Sarah J Shema; Sally L Glaser
Journal:  Cancer Causes Control       Date:  2009-12       Impact factor: 2.506

10.  Comparison of SEER Treatment Data With Medicare Claims.

Authors:  Anne-Michelle Noone; Jennifer L Lund; Angela Mariotto; Kathleen Cronin; Timothy McNeel; Dennis Deapen; Joan L Warren
Journal:  Med Care       Date:  2016-09       Impact factor: 3.178

View more
  10 in total

1.  Rural and urban patients with diffuse large B-cell and follicular lymphoma experience reduced overall survival: a National Cancer DataBase study.

Authors:  Andrew J Ritter; Jordan S Goldstein; Amy A Ayers; Christopher R Flowers
Journal:  Leuk Lymphoma       Date:  2019-01-11

2.  Initial cancer treatment and survival in children, adolescents, and young adults with Hodgkin lymphoma: A population-based study.

Authors:  Justine M Kahn; Frances B Maguire; Qian Li; Renata Abrahão; Jamie E Flerlage; Elysia Alvarez; Theresa H M Keegan
Journal:  Cancer       Date:  2021-09-08       Impact factor: 6.860

3.  Second primary malignancy risk after Hodgkin lymphoma treatment among HIV-uninfected and HIV-infected survivors.

Authors:  Renata Abrahão; Ann M Brunson; Justine M Kahn; Qian W Li; Ted Wun; Theresa H M Keegan
Journal:  Leuk Lymphoma       Date:  2022-01-06

4.  Late Effects in Survivors of Adolescent and Young Adult Acute Lymphoblastic Leukemia.

Authors:  Lori Muffly; Frances B Maguire; Qian Li; Vanessa Kennedy; Theresa H Keegan
Journal:  JNCI Cancer Spectr       Date:  2020-04-02

5.  Characterizing Lymphoma Incidence and Disparities for a Cancer Center Catchment Region.

Authors:  Amy A Ayers; Lin Lyu; Kaylin Dance; Kevin C Ward; Christopher R Flowers; Jean L Koff; Lauren E McCullough
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2019-06-26

6.  Perceptions of clinical care and research among African-American patients with lymphoma.

Authors:  Kaylin V Dance; Conner B Imbody; Lillian Chen; Lorna McNeill; Jackelyn B Payne; Christopher R Flowers
Journal:  Leuk Lymphoma       Date:  2021-02-28

7.  Young Adult Populations Face Yet Another Barrier to Care With Insurers: Limited Access to Proton Therapy.

Authors:  Andrew J Bishop; J Andrew Livingston; Matt S Ning; Isaac D Valdez; Cody A Wages; Mary Fran McAleer; Arnold C Paulino; David R Grosshans; Kristina D Woodhouse; Randa Tao; Michael E Roth; G Brandon Gunn; Susan L McGovern
Journal:  Int J Radiat Oncol Biol Phys       Date:  2021-03-04       Impact factor: 8.013

8.  Financial Hardship by Age at Diagnosis Including in Young Adulthood among African American Cancer Survivors.

Authors:  Theresa A Hastert; Julie J Ruterbusch; Judith Abrams; Mrudula Nair; Angie S Wenzlaff; Jennifer L Beebe-Dimmer; Stephanie S Pandolfi; Ann G Schwartz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2022-04-01       Impact factor: 4.090

9.  Comprehensive Assessment of Incidence, Risk Factors, and Mechanisms of Impaired Medical and Psychosocial Health Outcomes among Adolescents and Young Adults with Cancer: Protocol of the Prospective Observational COMPRAYA Cohort Study.

Authors:  Olga Husson; Marjolijn J L Ligtenberg; Lonneke V van de Poll-Franse; Judith B Prins; Martin J van den Bent; Mies C van Eenbergen; Renske Fles; Eveliene Manten-Horst; Jourik A Gietema; Winette T A van der Graaf
Journal:  Cancers (Basel)       Date:  2021-05-13       Impact factor: 6.639

10.  Chronic medical conditions and late effects following non-Hodgkin lymphoma in HIV-uninfected and HIV-infected adolescents and young adults: a population-based study.

Authors:  Renata Abrahão; Qian W Li; Marcio H Malogolowkin; Elysia M Alvarez; Raul C Ribeiro; Ted Wun; Theresa H M Keegan
Journal:  Br J Haematol       Date:  2020-02-20       Impact factor: 8.615

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.